Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition

H M Mehta1, M Futami2, T Glaubach1

  • 1Department of Pediatrics (Hematology-Oncology) and Cell and Molecular Biology, Lurie Children's Hospital of Chicago, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Leukemia
|October 31, 2013
PubMed

Insights

Granulocyte colony-stimulating factor receptor (GCSFR) class IV isoform is elevated in AML and promotes leukemia by enhancing proliferation and impairing differentiation, yet remains sensitive to JAK2 inhibitors.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Granulocyte colony-stimulating factor (GCSF) regulates neutrophil production via the GCSF receptor (GCSFR/CSF3R).
  • Mutations in GCSFR are linked to myelodysplasia/acute myeloid leukemia (AML) in children with severe congenital neutropenia.
  • Alternative splicing of CSF3R generates multiple isoforms, including class IV, whose biology is largely unknown.

Purpose of the Study:

  • To investigate the biological role and signaling of the alternatively spliced class IV GCSFR isoform.
  • To determine the impact of class IV GCSFR expression on cell proliferation, differentiation, and apoptosis in AML.
  • To assess the sensitivity of class IV GCSFR-mediated signaling to JAK2 inhibitors.

Main Methods:

  • Analysis of CSF3R isoform expression in adult myelodysplastic syndrome/AML patients.
  • Investigation of developmental regulation of CSF3R isoforms.
  • Phosphoprotein signaling analysis involving JAK-STAT pathways and cell cycle gene expression.
  • Assessment of proliferation, differentiation, and apoptosis in response to class IV GCSFR.

Main Results:

  • Class IV CSF3R expression is elevated in adult AML patients and is more representative of a progenitor cell stage.
  • Enhanced proliferation driven by class IV GCSFR is associated with diminished STAT3 and STAT5 activation.
  • Class IV GCSFR signaling remains sensitive to JAK2 inhibitors.
  • Alterations in the GCSFR C-terminal domain confer leukemic properties, including enhanced growth and resistance to apoptosis.

Conclusions:

  • The class IV GCSFR isoform may act as an oncogenic driver in AML.
  • Class IV GCSFR promotes leukemic properties through enhanced proliferation and impaired differentiation.
  • Targeting JAK2 may be a viable therapeutic strategy for AML patients with altered GCSFR.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K